Page 48 - SPEMD_58-2

104 rev port estomatol med dent cir maxilofac. 2017;58(2):97-104

14. da Mata AD, da Silva Marques DN, Silveira JM, Marques JR, de
Responsabilidades éticas Melo Campos Felino ET, Guilherme NF. Effects of gustatory
Proteção de pessoas e animais. Os autores declaram que para stimulants of salivary secretion on salivary pH and fow: a
randomized controlled trial. Oral Dis. 2009;15:220-8.
esta investigação não se realizaram experiências em seres 15. da Silva Marques DN, da Mata AD, Patto JM, Barcelos FA, de
humanos e/ou animais.
Almeida Rato Amaral JP, de Oliveira MC, Ferreira CG. Effects
of gustatory stimulants of salivary secretion on salivary pH
Confdencialidade dos dados. Os autores declaram ter seguido and fow in patients with Sjögrens syndrome: a randomized
os protocolos do seu centro de trabalho acerca da publicação dos controlled trial. J Oral Pathol Med. 2011;40:785-92.
dados de pacientes. 16. World Health Organization. Oral Health Survey Basic
Methods. 5th ed. France. WHO Library. 2013. p. 125.
17. Ferreira PL. Development of the Portuguese version of MOS
Direito à privacidade e consentimento escrito. Os autores SF-36. Part I Cultural and linguistic adaptation. Acta Med
declaram ter recebido consentimento escrito dos pacientes e/ou Port. 2000;13:55-66.
sujeitos mencionados no artigo. O autor para correspondência 18. Ferreira PL. Development of the Portuguese version of MOS
está na posse deste documento. SF-36. Part II -Validation tests. Acta medica portuguesa. Acta
Med Port. 2000;13:119-27.
19. Pires CP, Ferraz MB, de Abreu MH. Translation into Brazilian
Conflito de interesses Portuguese, cultural adaptation and validation of the oral
health impact profle (OHIP-49). Braz Oral Res. 2006;20:263-8.
Os autores declaram não haver confito de interesses. 20. Slade GD. The Oral Health Impact Profle. In: Slade GD (ed).
Measuring Oral Health and Quality of Life. Chapel Hill:
University of North Carolina, Dental Ecology. 1997;93-104.
21. Fleiss J. The design and analysis of clinical experiments. New
re ferências York. John Wiley & Sons, Inc. 1986. p. 448.
22. Bland J, Altman D. Cronbachs alpha. BMJ. 1997;314:572.
1. Al-Hashimi I. The management of Sjogrens syndrome in 23. Juniper E, Guyatt G, Roman J. How to develop and validate a
dental practice. J Am Dent Assoc. 2001;132:1409-17. new health-related quality of life instrument. In: Spilker B
2. Al-Hashimi I. Xerostomia secondary to Sjogrens syndrome (ed.). Quality of Life and Pharmacoeconomics in Clinical
in the elderly: recognition and management. Drugs Aging. Trials. 2nd ed. Philadelphia. PA: Lippincott-Raven Publishers.
2005;22:887-99. 1996;46-56.
3. Al-Hashimi I. Sjogrens syndrome: diagnosis and 24. Navazesh M, Kumar SK, University of Southern California
management. Womens Health (Lond). 2007;3:107-22. School of D. Measuring salivary fow: challenges and
4. Delaleu N, Jonsson R, Koller MM. Sjogrens syndrome. Eur J opportunities. J Am Dent Assoc. 2008;139(Suppl):35S-40S.
Oral Sci. 2005;113:101-13. 25. Marx R, Menezes A, Horovitz L, Jones E, Warren R. A
5. Binon PP, Fowler CN. Implant-supported fxed prosthesis comparison of two time intervals for test-retest reliability of
treatment of a patient with Sjogrens syndrome: a clinical health status instruments. J Clin Epidemiol. 2003;56:730-5.
report. Int J Oral Maxillofac Implants. 1993;8:54-8. 26. Holsinger FC, Bui DT. Anatomy, function, and evaluation of
6. Sreebny LM. Saliva in health and disease: an appraisal and the salivary glands. In: Myers EN, Ferris RL (ed.). Salivary
update. Int Dent J. 2000;50:140-61. Glands Disorders. New York. Springer Berlin Heidelberg.
7. Leung KC, McMillan AS, Leung WK, Wong MC, Lau CS, Mok 2007;1-16.
TM. Oral health condition and saliva fow in southern 27. Goodwin LD, Leech NL. Understanding Correlation: Factores
Chinese with Sjogrens syndrome. Int Dent J. 2004;54:159-65. that affect the size of r. J Exp Educ. 2006;74:249-66.
8. Pedersen AM, Bardow A, Nauntofte B. Salivary changes and 28. Direção Geral de Saúde. III Estudo Nacional de Prevalência
dental caries as potential oral markers of autoimmune das Doenças Orais. 2015. Portugal.
salivary gland dysfunction in primary Sjogrens syndrome. 29. Invernici MM, Nicolau GV, Soares de Lima AA. Management
BMC Clin Pathol. 2005;5:4. of Sjogrens Syndrome Patient: A Case Report of Prosthetic
9. Lopez-Jornet P, Camacho-Alonso F. Quality of life in patients Rehabilitation with 6-Year Follow-Up. Case Rep Dent.
with Sjogrens syndrome and sicca complex. J Oral Rehabil. 2014;2014:761251.
2008;35:875-81. 30. Shaghaghian S, Taghva M, Abduo J, Bagheri R. Oral health-
10. Stewart CM, Berg KM, Cha S, Reeves WH. Salivary dysfunction related quality of life of removable partial denture wearers
and quality of life in Sjogren syndrome: a critical oral- and related factors. J Oral Rehabil. 2015;42:40-8.
systemic connection. J Am Dent Assoc. 2008;139:291-9. 31. Seror R, Ravaud P, Mariette X, Bootsma H, Theander E,
11. Enger TB, Palm O, Garen T, Sandvik L, Jensen JL. Oral distress Hansen A, et al. EULAR Sjogrens Syndrome Patient
in primary Sjogrens syndrome: implications for health- Reported Index (ESSPRI): development of a consensus
related quality of life. Eur J Oral Sci. 2011;119:474-80. patient index for primary Sjogrens syndrome. Ann Rheum
12. Bullinger M. Assessing health related quality of life in Dis. 2011;70:968-72.
medicine. An overview over concepts, methods and 32. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM,
applications in international research. Restor Neurol Alexander EL, Carsons SE, et al. Classifcation criteria for
Neurosci. 2002;20:93-101. Sjogrens syndrome: a revised version of the European
13. Navazesh M. Methods for collecting saliva. Ann N Y Acad Sci. criteria proposed by the American-European Consensus
1993;694:72-7. Group. Ann Rheum Dis. 2002;61:554-8.